Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Role of Artificial Intelligence in polypharmacy and medication nonadherence in Saudi Arabia
0
Zitationen
6
Autoren
2024
Jahr
Abstract
Polypharmacy and medication nonadherence are growing global challenges in healthcare, especially among the older population.The rate of both is relatively high worldwide and in Saudi Arabia, with about 50% of chronic disease patients failing to comply with their treatment regimen.These issues should be countered to improve healthcare delivery systems and quality of life.AI integration into the patient care plan may assist prevent Polypharmacy's negative consequences and encourage patients to follow their prescribed course of action.In order to provide better patient care, numerous AI initiatives have been established both domestically and outside in Saudi Arabia.For maximum use, however, the introduction of AI presents ethical and technical issues that need to be resolved.Saudi Arabia has made strides toward integrating AI into healthcare through improved rates of AI literacy and easy accessibility.To get the most out of AI, more work is necessary to get over its constraints.
Ähnliche Arbeiten
Prediction of Creatinine Clearance from Serum Creatinine
1976 · 15.335 Zit.
A method for estimating the probability of adverse drug reactions
1981 · 11.448 Zit.
ECDEU Assessment Manual for Psychopharmacology
1976 · 8.823 Zit.
Adherence to Medication
2005 · 7.870 Zit.
Incidence of Adverse Drug Reactions in Hospitalized Patients
1998 · 4.798 Zit.